Udupi Bhavan Hotels Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 24-06-2024
- Paid Up Capital ₹ 1.25 Cr
as on 24-06-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 24-06-2024
- Revenue 119.85%
(FY 2018)
- Profit 4.16%
(FY 2018)
- Ebitda 19.71%
(FY 2018)
- Net Worth -220.28%
(FY 2018)
- Total Assets -10.41%
(FY 2018)
About Udupi Bhavan Hotels
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹3.50 M.
Ponnanmar Rajeevan and Manjusha Rajeevan serve as directors at the Company.
- CIN/LLPIN
U55100KL2016PTC047279
- Company No.
047279
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Udupi Bhavan Hotels?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ponnanmar Rajeevan  | Managing Director | 15-Nov-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manjusha Rajeevan | Director | 15-Nov-2016 | Current |
Financial Performance of Udupi Bhavan Hotels.
Udupi Bhavan Hotels Private Limited, for the financial year ended 2018, experienced significant growth in revenue, with a 119.85% increase. The company also saw a slight improvement in profitability, with a 4.16% increase in profit. The company's net worth observed a substantial decline by a decrease of 220.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Udupi Bhavan Hotels?
In 2018, Udupi Bhavan Hotels had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Steri Pharma Private LimitedActive 2 years 2 monthsPonnanmar Rajeevan and Manjusha Rajeevan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Dec 2017 | ₹3.50 M | Open |
How Many Employees Work at Udupi Bhavan Hotels?
Udupi Bhavan Hotels has a workforce of 6 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Udupi Bhavan Hotels, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Udupi Bhavan Hotels's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
